先看重点
在1159名老年人中,血液tau蛋白高且身体活动为中等或高水平者,认知下降速度比几乎不活动者分别慢58%和41%;tau蛋白低者中,高水平活动与慢27%相关。多处组间差异的置信区间包含0,且研究假设是在数据收集之后提出的。
证据类型
队列研究
解读依据
公开摘要
阅读重点
关联与混杂
研究在问什么
tau是一种在阿尔茨海默病中发生异常的脑蛋白,如今的血液检测使早期发现更方便。作者检验了在血液总tau蛋白高或低的人群中,身体活动在基线时和随时间推移是否与认知下降较慢有关。
研究了谁,如何研究
队列研究,数据来自芝加哥健康与衰老项目,这是在芝加哥4个社区开展的基于人群的研究,1993至2012年每3年为一个周期收集数据。对1159名分层随机抽样的参与者进行了包括采血在内的临床评估。身体活动为自报,按每周分钟数汇总:很少(至少4个项目都未参与)、中等(每周少于150分钟)和高(每周150分钟及以上)。结局为一组认知测验得出的整体认知功能。统计分析时间为2020年10月30日至2021年5月25日。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 11159名参与者的平均年龄(标准差)为77.4(6.0)岁,728人为女性(63%),696人为非裔美国人(60%)。
- 2tau蛋白高者中,中等水平身体活动者认知下降速度比几乎不活动者慢58%(差值0.038 SDU/年,95%CI 0.011-0.065),高水平活动者慢41%(差值0.027,95%CI -0.002至0.056)。
- 3tau蛋白低者中,中等水平活动者慢2%(差值0.001 SDU/年,95%CI -0.019至0.021),高水平活动者慢27%(差值0.014,95%CI -0.007至0.034)。
- 4单项认知测验显示出相似的结果。
局限与不确定性
- 1研究假设是在数据收集之后提出的,因此属于探索性分析。
- 2身体活动为自报,活动很少、中等和高水平的人群在健康状况、教育程度或其他习惯上也可能不同。
- 3多处组间差异的置信区间包含0,因此27%等百分比并不确定;只有tau蛋白高组中中等水平活动的差值不含0。
- 4样本年龄偏大,女性占63%,非裔美国人占60%,结论未必适用于其他人群。本解读仅基于摘要。
对日常健康的启示
在这个社区样本中,无论血液tau蛋白高低,更活跃的人晚年认知下降更慢。这些数据是观察性的,不能证明运动能保护大脑,血液tau蛋白结果也不是诊断。如对记忆有担忧或想制定安全的运动计划,请咨询医生。
如何联系自己的数据
可穿戴设备记录的步数或每周活动分钟数,便于你看自己是否达到本研究所用的每周150分钟界线,不过本研究的测量方式是自报。请用同一设备比较各周,并观察数月的趋势。
如何理解这类证据
暴露先于随访结局,仍可能存在混杂和反向因果。危险比不是个人绝对风险,也不等于已证明的干预效果。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Importance
Tau is a brain protein located in neurons and develops abnormally in individuals with Alzheimer disease. New technology is convenient for measuring blood total tau concentrations and provides a unique and increased opportunity for early intervention to slow cognitive decline.
Objective
To evaluate the association of physical activity and total tau concentrations with cognitive decline at baseline and over time.
Design, setting, and participants
The Chicago Health and Aging Project is a population-based cohort study conducted in 4 Chicago communities. Data collection occurred in 3-year cycles between 1993 and 2012. Participants completed in-home interviews. Clinical evaluations, which included blood samples, were performed with a stratified random sample of 1159 participants. Statistical analyses were conducted from October 30, 2020, to May 25, 2021.
Exposures
Physical activity and total serum tau concentrations. Data on physical activity were obtained through self-report items, and a sum of minutes per week was calculated. Little physical activity was defined as no participation in a minimum of 4 of the items on the physical activity measure. Medium activity was defined as participating in less than 150 minutes of physical activity per week, and high activity was defined as participating in 150 minutes or more of physical activity per week.
Main outcomes and measures
The main outcome for this study is global cognitive function, measured through a battery of cognitive tests. The study hypothesis was developed after data were collected.
Results
Of the 1159 participants in the study, 728 were women (63%), and 696 were African American (60%); the mean (SD) age was 77.4 (6.0) years, and the mean (SD) educational level was 12.6 (3.5) years. Participants with high total tau concentrations with medium physical activity had a 58% slower rate of cognitive decline (estimate, -0.028 standard deviation unit [SDU] per year [95% CI, -0.057 to 0.002 SDU per year]; difference, 0.038 SDU per year [95% CI, 0.011-0.065 SDU per year]), and those with high physical activity had a 41% slower rate of cognitive decline (estimate, -0.038 SDU per year [95% CI, -0.068 to -0.009 SDU per year]; difference, 0.027 SDU per year [95% CI, -0.002 to 0.056 SDU per year]), compared with those with little physical activity. Among participants with low total tau concentrations, medium physical activity was associated with a 2% slower rate of cognitive decline (estimate, -0.050 SDU per year [95% CI, -0.069 to -0.031 SDU per year]; difference, 0.001 SDU per year [95% CI, -0.019 to 0.021 SDU per year]), and high physical activity was associated with a 27% slower rate of cognitive decline (estimate, -0.037 SDU per year [95% CI, -0.055 to -0.019 SDU per year]; difference, 0.014 SDU per year [95% CI, -0.007 to 0.034 SDU per year]), compared with little physical activity. Individual tests of cognitive function showed similar results.
Conclusions and relevance
This study suggests that, among participants with both high and low total tau concentrations, physical activity was associated with slower cognitive decline. Results support the potential utility of blood biomarkers in measuring the benefits associated with health behaviors and may contribute to specifying target populations or informing interventions for trials that focus on improving physical activity behavior. Future work should examine the association of total tau concentrations with other health behaviors and physical activity types.
来源与署名
Longitudinal Association of Total Tau Concentrations and Physical Activity With Cognitive Decline in a Population Sample.
Desai P, Evans D, Dhana K, Aggarwal NT, Wilson RS, McAninch E, Rajan KB.
JAMA network open · 2021-08-02
DOI: 10.1001/jamanetworkopen.2021.20398 ↗PubMed · 34379124 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
运动对认知有小到中等程度的改善:133项系统评价的伞状综述
对133项系统评价(共2724项试验、258,279名参与者)的伞状综述发现,运动改善了总体认知(SMD 0.42,95% CI 0.37至0.47)、记忆(0.26)和执行功能(0.24),记忆改善在儿童和青少年中最大,执行功能改善在注意缺陷多动障碍(ADHD)患者中最大。多数评价(94项)质量被评为极低,评级最好的评价中效应更小(总体认知为0.23),而且结局是测试得分,不是痴呆。
British Journal of Sports Medicine
每天步数越多,抑郁症状越少:33项观察性研究的荟萃分析
荟萃分析汇总了33项观察性研究、共96,173名成年人,每日步数越多,抑郁症状越少;在可合并的2项前瞻性队列中,每天走7000步及以上者的抑郁风险低于少于7000步者(RR 0.69,95% CI 0.62至0.77)。多数研究是横断面研究,情绪低落也可能让人走得更少,作者还指出预测区间提示结论需谨慎对待。
JAMA Network Open
运动可缓解抑郁,但证据把握度低:218项试验的网状荟萃分析
这项网状荟萃分析汇总了218项试验、14,170名符合重性抑郁诊断标准的参与者,与积极对照相比,步行或慢跑、瑜伽、力量训练、混合有氧运动以及太极或气功都使抑郁症状出现中等程度的下降(步行或慢跑的Hedges’ g −0.62,95%可信区间−0.80至−0.45)。不过只有一项研究达到低偏倚风险标准,因此证据把握度对步行或慢跑为低,对其他疗法为极低。
BMJ
身体活动可减轻抑郁和焦虑:97项系统评价的伞状综述
97项系统评价汇总了1039项随机对照试验、128,119名参与者,与常规照护相比,身体活动对抑郁(中位数效应量−0.43)和焦虑(−0.42)有中等程度的改善,强度越高改善越大。不过其中77项综述的质量被评为极低,证据主要针对轻至中度症状。
British Journal of Sports Medicine

